Company
Location
Business Summary
Develops medical device products based on the human protein tropoelastin to treat atrophic scars, burn and chronic wounds, and the rejuvenation of aging skin.
Clinical stage biopharmaceutical company that develops cell therapy and regenerative medicine for the treatment of liver diseases with no effective therapeutic cure including UCD and ACLF.
Clinical stage biopharmaceutical company that develops cell therapy and regenerative medicine for the treatment of multiple diseases including Spinocerebellar Ataxia (“SCA”) and Acute Liver Failures.
Clinical stage biopharmaceutical company that develops MSCs products for the treatment of multiple diseases including Acute Spinal Cord Injuries and Acute Respiratory Distress Syndrome(“ARDS”).
Clinical stage biopharmaceutical company that develops novel extracellular matrix targeting drugs including a disease-modifying osteoarthritis (“OA”) drug.